TherapeuticsMD, Inc. (NASDAQ:TXMD)

About the company

TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.


Health Technology


Pharmaceuticals: Generic




Total Revenue




Market Capitalization


Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin


Operating Margin (in %)

Total operating margin


Net Margin (in %)

Total net margin


Dividend Yield (in %)

Dividend per share


Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Zoetis, Inc. ZTS 65945.10 6339.00 23.64 41.05 25.41
Mylan NV MYL 8323.70 11624.00 0.74 134.17 0.54
BridgeBio Pharma, Inc. BBIO 3821.18 41.00 10.06 -13.16 -718.08
Taro Pharmaceutical Industries Ltd. TARO 2474.94 645.00 1.18 10.26 37.88
TherapeuticsMD, Inc. TXMD 381.00 58.00 -8.82 -1.95 -333.88
LifeVantage Corp. LFVN 191.55 230.00 6.42 16.16 5.06
Abeona Therapeutics, Inc. ABEO 186.62 3.00 1.91 -1.84 75.95
Kindred Biosciences, Inc. KIN 151.71 4.00 2.53 -2.22 None
Cocrystal Pharma, Inc. COCP 62.65 2.00 2.29 -1.08 -733.84
China Pharma Holdings, Inc. CPHI 23.76 10.00 2.84 -1.10 -214.63
Jaguar Health, Inc. JAGX 6.25 5.00 4.63 0.10 -887.14

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

TherapeuticsMD Inc.

10d ago, source: MarketWatch

Director 10,000 Acquisition at $2.99 per share. 29,900 ...

TherapeuticsMD Inc (NASDAQ:TXMD) Expected to Earn FY2021 Earnings of ($0.31) Per Share

8d ago, source:

Analysts at Cantor Fitzgerald issued their FY2021 earnings estimates for TherapeuticsMD in a report released on Thursday, ...

Hedge Funds Are Dumping TherapeuticsMD Inc (TXMD)

17d ago, source: YAHOO!

In this article, we analyze how these elite funds and prominent investors traded TherapeuticsMD Inc (NASDAQ:TXMD) based on those filings. Is TherapeuticsMD Inc (NASDAQ:TXMD) a cheap investment today?

Is Avid Bioservices, Inc. (CDMO) Going to Burn These Hedge Funds?

7d ago, source: YAHOO!

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of ...

Financials TherapeuticsMD

13d ago, source: Business Insider

© 2020 Insider Inc. and GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...

TherapeuticsMD (NASDAQ:TXMD) Upgraded by BidaskClub to Sell

3d ago, source: Stock Market Daily

TherapeuticsMD stock has undergone multiple analysts rating changes in the recent past. TherapeuticsMD Upgraded by BidaskClub ...

Global Women?s Health Market

13d ago, source:

Inc., TherapeuticsMD, Inc., Bausch Health, Vertical Pharmaceuticals, LLC, Veru Inc., BD and AbbVie Inc. among others. Market ...

Portfolio items

Follow companies to create your optimal portfolio.
Refresh this page to see your newly added stocks.